|
2012 Announcements |
|
|
|
Result of Annual General Meeting | |
|
|
|
|
Proximagen notes positive vote from FDA in respect of Arena’s 5-HT2c agonist lorcaserin | |
|
|
|
|
|
|
|
|
|
|
|
|
Notification of 2011 Preliminary Results | |
|
|
|
|
Notification of Interest in Shares | |
|
|
|
|
Notification of Interest in Shares | |
|
|
|
2011 Announcements |
|
|
|
Notification of Interest in Shares | |
|
|
|
|
Proximagen and Altacor sign agreement for 5HT2c | |
|
|
|
|
Notification of Interest in Shares | |
|
|
|
|
Notification of Interest in Shares | |
|
|
|
|
Notification of Interest in Shares | |
|
|
|
|
Notification of Interest in Shares | |
|
|
|
|
|
|
|
|
Proximagen signs strategic partnership agreement with Lundbeck | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notification of Interest in Shares | |
|
|
|
|
Result of Annual General Meeting | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notification of Preliminary Results | |
|
|
|
|
Total Voting Rights Update | |
|
|
|
|
|
|
|
|
|
|
|
2010 Announcements |
|
|
|
Proximagen acquires two CNS drug development programmes from GlaxoSmithKline | |
|
|
|
|
|
|
|
|
Director and Senior Management share purchases | |
|
|
|
|
Upsher-Smith Laboratories Inc increases its stake in Proximagen | |
|
|
|
|
Director's Share Purchase | |
|
|
|
|
Total Voting Rights Update | |
|
|
|
|
Directors’ share purchases | |
|
|
|
|
Proximagen announces sale of sabcomeline | |
|
|
|
|
|
|
|
|
|
|
|
|
Notification of Interest in Shares | |
|
|
|
|
NIH funds Phase II clinical trial on naluzotan | |
|
|
|
|
Annual Report and Accounts | |
|
|
|
|
Result of Annual General Meeting | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proximagen Sublicenses Rights to Tonabersat | |
|
|
|
|
Grant of New Share Options | |
|
|
|
|
|
|
|
|
Notification of Preliminary Results | |
|
|
|
|
Proximagen announces positive efficacy results in NIH epilepsy studies | |
|
|
|
|
Compulsory Acquisition of Outstanding Minster Shares | |
|
|
|
|
Offer for Minster declared unconditional | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recommended Cash Offer
document | |
|
|
|
|
Posting of Offer document | |
|
|
|
|
Recommended Cash Offer for Minster Pharmaceuticals Plc | |
|
|
|
|
2009 Announcements |
|
|
|
Completion of Acquisition of Cambridge Biotechnology Ltd | |
|
|
|
|
Proximagen Acquires Cambridge Biotechnology Ltd | |
|
|
|
|
Letter of Intent to acquire Cambridge Biotechnology | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Result of Annual General Meeting | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Result of Annual General Meeting | |
|
|
|
|
|
|
|
|
Notice of Annual Report and Accounts | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008 Announcements |
|
|
|
Directors' Share Purchase | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Milestone and equity investment | |
|
|
|
|
Declaration of Major Shareholding | |
|
|
|
|
|
|
|
|
|
|
|
|
Declaration of Major Shareholding | |
|
|
|
|
Proximagen Signs $232 Million Licensing Agreement with Upsher-Smith | |
|
|
|
|
Proximagen 2008 AGM Proxy form | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 Announcements |
|
|
|
Director/PDMR Shareholding | |
|
|
|
|
|
|
|
|
Termination of Offer Period | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of Information | |
|
|
|
| Notice of Interim Results | |
|
|
|
|
|
|
|
| Statement RE: Possible Offer | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Annual Report and AGM Date | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Annual Report and AGM Date | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 Announcements |
|
|
|
|
|
|
| Symposium and Pipeline Update | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 Announcements |
|
|
|
|
|
|
|
|
pdf